Roche Navigation Menu InfoMedics : InfoMedics
  • Accedi
  • Esci
  • Cerca nel sito
Roche
  • Fino
  • Home
  • Search
  • Close search

						
							

Searching

    • Home
    • Patologie
      Patologie Overview
      • Oncologia
      • Carcinoma Basocellulare
      • Carcinoma della Cervice Uterina
      • Carcinoma del Colon-Retto
      • Carcinoma Gastrico
      • Carcinoma Mammario
      • Carcinoma Ovarico
      • Carcinoma Polmonare
      • Carcinoma Uroteliale
      • Glioblastoma
      • Melanoma
      • Ematologia e Oncoematologia
      • LLC
      • LMC
      • HCL
      • LNH
      • Anemia chemio-indotta
      • Reumatologia
      • Vasculiti dei piccoli vasi
      • Respiratorio
      • Fibrosi Cistica
      • Fibrosi Idiopatica Polmonare
      • Neuroscienze
      • Sclerosi multipla
      • Morbo di Parkinson
      • Dolore
      • Infettivologia
      • HIV/AIDS
      • Influenza
      • Infezioni batteriche
      • Nefrologia e trapianti
      • Anemia Renale
    • Prodotti
      Prodotti Overview
      • Oncologia
      • Alecensa
      • Avastin
      • Cotellic-Zelboraf
      • Erivedge
      • Herceptin
      • Perjeta
      • Tarceva
      • Ematologia e Oncoematologia
      • Gazyvaro
      • Mabthera in oncologia
      • Respiratorio
      • Pulmozyme
      • Esbriet
      • Neuroscienze
      • OCREVUS
      • Infetivologia
      • Fuzeon
      • Rocefin
      • Tamiflu
      • Nefrologia e Trapianti
      • Cellcept
    • Immunoterapia
      Immunoterapia Overview
    • Biomarcatori
      Biomarcatori Overview
    • Servizi
      Servizi Overview
      • Servizi
      • Biotecnologie
      • Materiale per i pazienti
      • Medical information
      • Ricerca su PubMed
      • Health in-Law
      • Le dimensioni del valore in sanità
      • PAIRS
      Spotlight Health in-Law

    • Link Utili
      Link Utili Overview
      • Link utili
      • Database scientifici
      • Riviste online
      • Congressi
      Spotlight Medical Information

    • RCP
      RCP Overview
    • Materiale Educazionale
      Materiale Educazionale Overview
    • Home
    • Patologie
      • Oncologia
        • Carcinoma Basocellulare
        • Carcinoma della Cervice Uterina
        • Carcinoma del Colon-Retto
        • Carcinoma Gastrico
        • Carcinoma Mammario
        • Carcinoma Ovarico
        • Carcinoma Polmonare
        • Carcinoma Uroteliale
        • Glioblastoma
        • Melanoma
      • Ematologia e Oncoematologia
        • LLC
        • LMC
        • HCL
        • LNH
        • Anemia chemio-indotta
      • Reumatologia
        • Vasculiti dei piccoli vasi
      • Respiratorio
        • Fibrosi Cistica
        • Fibrosi Idiopatica Polmonare
      • Neuroscienze
        • Sclerosi multipla
        • Morbo di Parkinson
        • Dolore
      • Infettivologia
        • HIV/AIDS
        • Influenza
        • Infezioni batteriche
      • Nefrologia e trapianti
        • Anemia Renale
    • Prodotti
      • Oncologia
        • Alecensa
        • Avastin
        • Cotellic-Zelboraf
        • Erivedge
        • Herceptin
        • Perjeta
        • Tarceva
      • Ematologia e Oncoematologia
        • Gazyvaro
        • Mabthera in oncologia
      • Respiratorio
        • Pulmozyme
        • Esbriet
      • Neuroscienze
        • OCREVUS
      • Infetivologia
        • Fuzeon
        • Rocefin
        • Tamiflu
      • Nefrologia e Trapianti
        • Cellcept
    • Immunoterapia
    • Biomarcatori
    • Servizi
      • Servizi
        • Biotecnologie
        • Materiale per i pazienti
        • Medical information
        • Ricerca su PubMed
        • Health in-Law
        • Le dimensioni del valore in sanità
        • PAIRS
    • Link Utili
      • Link utili
        • Database scientifici
        • Riviste online
        • Congressi
    • RCP
    • Materiale Educazionale
    • Accedi
    • Esci
    Chiudi

    1 - of risultati per ""

    No results

    Sei un operatore sanitario? Registrati ora per accedere ai contenuti dell'Area Riservata

    Registrati
    • Uno sguardo sulle vasculiti

      Scopri di più

    • Vasculiti dei piccoli vasi
    • Descrizione
    • Sintomi
    • Terapia
    • Letteratura
    • Link utili
    • Congressi
    • Più
      • Descrizione
      • Sintomi
      • Terapia
      • Letteratura
      • Link utili
      • Congressi

    Sei qui:

    1. Patologie
    2. Vasculiti dei piccoli vasi
    3. Letteratura

    Letteratura

    • Bosch X, Guilabert A, Espinosa G, Mirapeix E. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 2007;298:655–69.
    • Calabrese LH, Molloy ES, Duna G. Antineutrophil cytoplasmic antibody-associated vasculitis. In: Firestein GS, Kelley WN, eds. Kelley's Textbook of Rheumatology. 8th ed. Philadelphia, PA: Saunders/Elsevier; 2009.
    • Chen M, Kallenberg CG. The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 2010;9:A293–8.
    • Drooger JC, Dees A, Swaak AJ. ANCA-positive patients: The influence of PR3 and MPO antibodies on survival rate and the association with clinical and laboratory characteristics. Open Rheumatol J 2009;3:14–7.
    • Falk RJ, Jennette JC. ANCA disease: where is this field heading? J Am Soc Nephrol 2010;21:745–52.
    • Falk RJ, King TE, Stone JH. Clinical manifestations and diagnosis of Wegener’s granulomatosis and microscopic polyangiitis: UpToDate; 2010.
    • Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: summary. Arthritis Rheum 1990;33:1135–6.
    • Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 2011;50:1916–20.
    • Gomez-Puerta JA, Bosch X. Antineutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update. Am J Pathol 2009;175:1790–1798.
    • Gómez-Puerta JA, Hernandez-Rodriguez J, Lopez-Soto A, Bosch X. Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest. 2009;136:1101–11.
    • Guillevin L. Polyarteritis nodosa and microscopic polyangiitis. In: Ball GV, Bridges SL, eds. Vasculitis. Oxford: Oxford University Press, 2002:300–20.
    • Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int
    • Hamour S, Salama AD, Pusey CD. Management of ANCA-associated vasculitis: current trends and future prospects. Ther Clin Risk Manag 2010;6:253–64.
    • Hellmich B, Flossmann O, Gross WL, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007;66:605–17.
    • Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488–98.
    • Hoffman GS, Langford CA. Are there different forms of life in the antineutrophil cytoplasmic antibody universe? Ann Intern Med 2005;143:683–5.
    • Holle JU, Laudien M, Gross WL. Clinical manifestations and treatment of Wegener’s Granulomatosis. Rheum Dis Clin North Am 2010;36:507–26.
    • Hunder GG. Classification of and approach to the vasculitides in adults: In: Stone JH (ed). UpToDate. Waltham, MA: UpToDate; 2010.
    • Jayne D, Rasmussen N, Andrassy K, Bacon P, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36–44.
    • Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis,1994.
    • Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiologic potential. Kidney Int 1994;46:1–15.
    • Kallenberg CG. Pathophysiology of ANCA-associated small vessel vasculitis. Curr Rheumatol Rep 2010;12:399–405.
    • Khasnis A, Langford CA. Update on vasculitis. J Allergy Clin Immunol 2009;123:1226–36.
    • King TE. Clinical features and diagnosis of Churg-Strauss syndrome (allergic granulomatosis and angiitis): UpToDate;2010a.
    • King TE. Epidemiology, pathogenesis, and pathology of Churg-Strauss syndrome (allergic granulomatosis and angiitis): UpToDate;2010b.Rheum 1994;37:187–92.1998;53:743–53.
    • Lamprecht P, Gross WL. Wegener’s granulomatosis. Herz 2004;29:47–56.
    • Lane SE, Watts RA, Scott DGI. Primary systemic vasculitis: clinical features and mortality. Q J Med 2005;98:97–112.
    • Langford CA. Vasculitis. J Allergy Clin Immunol 2010;125(2 Suppl. 2):S216–S225.
    • Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984;63:65–81.
    • Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101–7.
    • Lightfoot RW, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088–94.
    • Linder R, Orth I, Hagen EC, et al. Differentiation between Wegener's granulomatosis and microscopic polyangiitis by an artificial neural network and by traditional methods. J Rheumatol 2011;38:1039–47.
    • Lionaki S, Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol 2007;29:459–74.
    • Luqmani RA, Exley AR, Kitas GD, et al. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 1997;11:423–46.
    • Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094–100.
    • Mukhtyar C, Flossmann O, Hellmich B, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 2008;67:1004–10.
    • Mukhtyar C, Guillevin L, Cid MC, et al.; European Vasculitis Study Group. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009;68:310–7
    • Ntatsaki E, Watts RA, Scott DG. Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am 2010;36:447–61.
    • Popa ER, Stegeman CA, Bos NA, et al. Differential band T-cell activation in Wegener’s granulomatosis. J Allergy Clin Immunol 1999;103:885–94.
    • Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000;57:846–62.
    • Specks U, Wheatley CL, McDonald TJ, Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc 1989;64:28–36.
    • Stassen PM, Derks RP, Kallenberg CG, Stegeman CA. Venous thromboembolism in ANCA-associated vasculitis – incidence and risk factors. Rheumatology (Oxford) 2008;47:530–4. 
    • Stone J, Merkel P, Seo P, et al. Long-term results of the RAVE Trial: Which disease subsets are at greatest risk for disease flare? Presented at the American College of Rheumatology (ACR) congress, 2011.
    • Stone JH. The classification and epidemiology of systemic vasculitis. In: Firestein GS, Kelley WN, eds. Kelley's textbook of rheumatology. 8th ed. Philadelphia, PA: Saunders/Elsevier; 2009. Stone JH.
    • The antineutrophil cytoplasmic antibody-associated vasculitides: Wegener’s granulomatosis, microscopic polyangiitis, and the Churg-Strauss syndrome. In: Klippel JH, Stone JH, Crofford LJ, White PH, eds. Primer on the Rheumatic Diseases. 13th ed. New York, NY: Springer; 2008.
    • Suppiah R, Robson J, Luqmani R. Outcome Measures in ANCA-associated Vasculitis. Rheum Dis Clin North Am 2010;36:587–607.
    • Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 2010;55:429–44.
    • Tsiveriotis K, Tsirogianni A, Pipi E, et al. Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected Greek patients. Autoimmune Dis  2011;2011:626495.
    • Villiger PM, Guillevin L. Microscopic polyangiitis: Clinical presentation. Autoimmun Rev 2010;9:812–9.
    • Voswinkel J, Müller A, Lamprecht P. Is PR3-ANCA formation initiated in Wegener’s granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Ann N Y Acad Sci 2005;1051:12–9.
    • Voswinkel J, Müller A, Kraemer JA, et al. B lymphocyte maturation in Wegener’s granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006;65:859–64.
    • Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007;66:222–7.
    • Watts RA, Lane SE, Scott DG et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001;60:1156–7.
    • Westman KW, Bygren PG, Olsson H, et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998;9:842–52.
    • Wiik A. Rational use of ANCA in the diagnosis of vasculitis. Rheumatology (Oxford). 2002;41:481–3.

     

    Videopillole

    • 21.12.2017

      Parola agli esperti sulle vasculiti ANCA-associate

      scopri

    Link utili

    • 21.12.2017

      Link utili

      scopri

    • © 2023
    • 07.11.2022
    • Privacy policy
    • Termini e condizioni
    • Contatti
    • Informativa cookie
    • Cookie settings

    • Twitter
    • LinkedIn
    • YouTube